Key facts
- It has raised $4.5M across 1 recorded rounds; the latest was Seed Round ($300K) in Apr 2025.
- Notable investors include BioGenerator Ventures, Arch Grants, Missouri Technology Corporation, Centennial Investors.
- Buck Surgical has filed 1 Form D with the SEC, most recently Apr 2025 ($300K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Buck Surgical
Funding rounds
1 roundsAbout Buck Surgical
Developer of vascular surgery coupling technology designed to improve surgical care and expand patient access to life. The company develops surgical care that improves outcomes, helps to modernize limb-preservation treatments in vascular and gastrointestinal surgery, enabling healthcare professionals to use advanced surgical devices and provide care to patients.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2021
- Employees
- 2
- Website
- bucksurgical.com/
- Ownership
- Privately Held (backing)
Buck Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Buck Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Buck Surgical in its N-PORT filings yet. We sweep new filings monthly.